NTRB
NutriBand Inc.
$3.06
-0.03 (-0.97%)
At close · Jul 2
Going-concern doubt
— cleared Jun 11, 2026
The latest filing states the doubt was alleviated.
“Management believes the substantial doubt about the ability of the Company to continue as a going concern is alleviated by the above assessment.”View the 10-Q filed Jun 11, 2026
Market Cap
$37.20M
Shares
12,155,983
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$3.06
Open$3.13
Day$3.03–3.19
52W$2.90–11.68
Avg vol 30d13K
Short int179K · 1.5% float · 19.7d
Short vol27%
DataOct 2021–Jul 2026
Filing10-Q · Jun 11
Equibles Rating
blended score · not investment advice
Overall
Sell
Technical · trend & momentum
Sell
◦
50 / 200-day cross
no cross
−
Price vs 200-day avg
−35% below
−
Price vs 50-day avg
−13% below
◦
RSI (14)
40 · neutral
+
MACD trend
positive
−
52-week position
2% · near low
Sentiment · smart money
Bearish
◦
Trend (MA cross)
50d $4 › 200d $5 — 200d above 50d
−
Institutional flow
-26% holders QoQ · +3 funds added
◦
Insider flow
No net insider activity over 90 days
−
Short interest
1.47% of float · ▲ +3.7% MoM · 19.7 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
14 holders — mid 3-yr range
Fundamentals
Weak
−
Revenue growth
−5% Y/Y
◦
Gross margin
28%, contracting
−
EPS growth
−161% Y/Y
−
Free cash flow
$-5.1M
+
Balance sheet
net cash $2.6M
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
FQ2-27 quarter ends
~Jul 31, 2026
Est
filed Jun 11, 2026
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
−35% below
Bearish
Price vs 50-day avg
−13% below
Bearish
RSI (14)
40 · neutral
Neutral
MACD trend
positive
Bullish
52-week position
2% · near low
Bearish
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $4 › 200d $5 — 200d above 50d
Institutional flow
Distributing
-26% holders QoQ · +3 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
1.47% of float · ▲ +3.7% MoM · 19.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
14 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $3
Now $3 · 2%
52-wk high $12
vs 200-day avg -35%
vs 50-day avg -13%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
NTRB
this stock
NutriBand Inc.
|
$37.20M | -32.6% | -4.8% | — | 1.5% |
|
AKTX
Akari Therapeutics Plc
|
$953.21B | -9.9% | — | — | 0.0% |
|
ONC
BeOne Medicines Ltd.
|
$470.30B | -2.0% | +22179.2% | 957.1 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$134.02B | +16.5% | +46.2% | 31.3 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.80B | -15.1% | +20.8% | 16.3 | 3.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| NTRB | +1.0% | -12.8% | -30.8% | -4.1% | -32.6% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | -0.4% | -11.6% | -38.8% | -3.8% | -41.8% |